InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Kharabi Darius, Directeur Commercial. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 11 reports have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €57k. Activity tracked since 4 January 2023. The latest transaction was filed on 22 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kharabi Darius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
20,806 shares@ US$0.8326.1% of flowCommon StockSEC:0001893729-25-000003:0
4,511 shares@ US$4.0136.9% of flowCommon StockSEC:0001415889-25-018321:0
730 shares@ US$3.749.0% of flowCommon StockSEC:0001415889-25-015681:0
10,100 shares0Common StockSEC:0001415889-25-001063:0
5,158 shares@ US$4.7594.6% of flowCommon StockSEC:0001415889-24-018376:0
231 shares@ US$6.095.4% of flowCommon StockSEC:0001415889-24-015225:0
4,600 shares0Common StockSEC:0001415889-24-000771:0
36,847 shares0Common StockSEC:0001415889-23-010287:0
9 sharesCommon StockSEC:0001415889-23-009138:0
9,525 shares0Common StockSEC:0001415889-23-000641:0
295,657 sharesCommon StockSEC:0001415889-21-005280:0
11 of 11 declarations
About Kharabi Darius
Kharabi Darius is Directeur Commercial and has reported 11 filings. Across the 11 filings on record, the sampled recent filings show sales only, with total proceeds of EUR 57091, between 2021-11-17 and 2025-10-24, mainly in KALA BIO, Inc. and Kala Pharmaceuticals, Inc.
